If you are currently taking a compounded version, considering one, or trying to make sense of the warnings you've been seeing, this guide explains exactly where things stand right now and what the actual risks look like
38,39,40 The phenotype observed after GLP-1R knockout (KO) includes various physiological and metabolic changes
PubMed Central, Weghuber, Daniel, et al
Yes, pharmaceutical companies are developing additional dual and triple agonist medications
Fibre-rich foods: Soluble and fermentable fibres regulate blood sugars and diversify the guts flora
This challenge is why some scientists question whether oral GLP-1 drugs can be as potent as injectables, Cavender says